Ohio State Navbar

Sign In

RSS Feed Regenerative Medicine News

BUSM Study Shows Potential of Differentiated iPS Cells in Cell Therapy without Immune Rejection 


January 28, 2013 - (Boston University School of Medicine) - "The study, published online in Cell Stem Cell, demonstrates the potential of utilizing iPS cells to develop cell types that could offer treatment for a wide range of conditions, including diabetes, liver and lung diseases, without the barrier of immune rejection." Read Full Article


Posted on 4-Feb-13 by Gallerno, Jacob
Tags: Science and Industry News
Trackback Url  |  Link to this post | Bookmark this post with: